Literature DB >> 33065817

Utilizing placebos to leverage effects of cognitive-behavioral therapy in patients with depression.

Nina Jurinec1, Anne Schienle2.   

Abstract

BACKGROUND: Patients with depression often experience difficulties with completing homework assignments during cognitive-behavioral therapy (CBT). In the present study, we investigated the effects of a specific placebo which aimed at improving the practice of a daily relaxation exercise during a four-week outpatient program.
METHODS: A total of 126 patients diagnosed with major depressive disorder were randomly assigned to one of three groups: 'Coping with Depression' course, 'Coping with Depression' course with additional daily placebo treatment, and waiting-list group. The placebo (sunflower oil) was introduced as a natural medicine to help the patients focus on their inner strengths and to mobilize their bodies' natural healing powers. The placebo was taken orally before the daily relaxation exercise.
RESULTS: The placebo improved homework quantity and quality (both p < .001). The placebo group practiced more often and experienced greater relaxation effects than the no-placebo group. Additionally, the placebo group showed a greater reduction of depression symptoms (p < .001). LIMITATIONS: The primary limitation of the study is the lack of a psychophysiological measure of relaxation.
CONCLUSIONS: Placebos can be used to leverage CBT effects in patients with depression.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Depression; Enhancement of self-efficacy; Homework compliance; Placebo; Relaxation

Mesh:

Year:  2020        PMID: 33065817     DOI: 10.1016/j.jad.2020.08.087

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  4 in total

1.  Combined Cognitive-Behavioral Therapy and Placebo Treatment for Patients with Depression: A Follow-Up Assessment.

Authors:  Anne Schienle; Nina Jurinec
Journal:  Psychol Res Behav Manag       Date:  2021-02-22

Review 2.  Importance of Non-pharmacological Approaches for Treating Irritable Bowel Syndrome: Mechanisms and Clinical Relevance.

Authors:  Albert Orock; Tian Yuan; Beverley Greenwood-Van Meerveld
Journal:  Front Pain Res (Lausanne)       Date:  2021-01-21

3.  Open-label placebos as adjunctive therapy for patients with depression.

Authors:  Anne Schienle; Nina Jurinec
Journal:  Contemp Clin Trials Commun       Date:  2022-06-16

4.  Open-label placebo treatment to improve relaxation training effects in healthy psychology students: a randomized controlled trial.

Authors:  Anne Schienle; Isabella Unger
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.